Fibrolean
Natural health product licensed in Canada
- Other names
- Cholest-Low, Cholesterol Protocol, Cholesterol Support, Glucomannan, Glucomannan 1000 mg
- Licence holder
- Vitaminol Inc.
- NPN or DIN-HM
- 80039610
- Status
- Active licence
- Licence date
- 7 February 2013
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Stéarate de magnésium, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 3 days |
Uses authorised in Canada
(Used in Herbal Medicine as a) bulk-forming laxative. (Used in Herbal Medicine to) promote(s) bowel movements by increasing bulk volume and water content. (Used in Herbal Medicine to) provide(s) gentle relief of constipation and/or irregularity. Helps to lower cholesterol levels (by reducing cholesterol absorption from the gastrointestinal tract).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you have symptoms such as abdominal pain, nausea, vomiting or fever (as these could be signs of abnormal constrictions of the gastrointestinal tract, diseases of the oesophagus and/or the superior opening of the stomach (cardia), potential or existing intestinal blockage, paralysis of the intestine, megacolon, faecal impaction, inflamed bowel or appendicitis). Consult a health care practitioner if symptoms worsen or if laxative effect does not occur within 7 days. Consult a health care practitioner prior to use if you have diabetes. Consult a health care practitioner prior to use if you are pregnant or breastfeeding.
- Effets indésirables connus
Loose stools, flatulence, diarrhea, and abdominal discomfort have been reported. If you experience chest pain, vomiting, or difficulty swallowing or breathing after taking the product, seek immediate medical attention.
- Contre-indications
Do not use if you have difficulty swallowing.
Source
Official Health Canada record, licence 80039610
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.